KAVANAGH SARAH B
SEC CIK 1681171 · EDGAR
Most active insiders at BLCO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Munsch Frederick | SVP, CAO, Ctrl | — | $887.7K |
| 2 | VON ESCHENBACH ANDREW C. | Dir | $79.9K | $306.7K |
| 3 | COLLIS STEVEN H | Dir | $267.1K | — |
| 4 | SAUNDERS BRENT L | COB, CEO, Dir | $252.0K | — |
| 5 | Bailey A Robert D | EVP, CLO | $250.4K | — |
| 6 | Ross Thomas W. Sr. | Dir | $79.6K | — |
| 7 | ROBERTSON RUSSEL C | Dir | $78.8K | — |
| 8 | Alfonso Eduardo | Dir | $77.0K | — |
| 9 | Ling Karen | Dir | $71.0K | — |
| 10 | Eldessouky Sam | EVP, CFO | $68.5K | — |
| 16 | KAVANAGH SARAH B | Dir | — | — |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-28 17:04 | 2026-05-26 | BLCO | Bausch & Lomb Corp | KAVANAGH SARAH B | Dir | A - Grant | $15.78 | +15.8K | 69.5K | +30% | +$250.0K | |
| 2026-05-26 18:19 | 2026-05-22 | BHC | Bausch Health Companies Inc. | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +45.9K | 282.2K | +19% | $0 | |
| 2025-05-28 | 2025-05-27 | BLCO | Bausch & Lomb Corp | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +20.3K | 53.7K | +61% | $0 | |
| 2025-05-20 | 2025-05-16 | BHC | Bausch Health Companies Inc. | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +54.3K | 236.4K | +30% | $0 | |
| 2024-08-06 | 2024-08-02 | BLCO | Bausch & Lomb Corp | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +14.7K | 33.4K | +79% | $0 | |
| 2024-05-20 | 2024-05-17 | BHC | Bausch Health Companies Inc. | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +35.4K | 182.0K | +24% | $0 | |
| 2023-05-19 | 2023-05-19 | BHC | Bausch Health Companies Inc. | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +29.2K | 146.7K | +25% | $0 | |
| 2023-05-05 | 2023-05-04 | BLCO | Bausch & Lomb Corp | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +12.9K | 18.7K | +221% | $0 | |
| 2023-04-26 | 2023-04-24 | BLCO | Bausch & Lomb Corp | KAVANAGH SARAH B | Dir | F - Tax | $17.12 | -6,692 | 5,808 | -54% | -$114.6K | |
| 2022-06-28 | 2022-06-24 | BHC | Bausch Health Companies Inc. | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +34.4K | 117.4K | +41% | $0 | |
| 2022-05-12 | 2022-05-10 | BLCO | Bausch & Lomb Corp | KAVANAGH SARAH B | Dir | A - Grant | $0.00 | +12.5K | 12.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations